FDA Inspection 1032074 — Jilin Shulan Synthetic Pharmaceutical Co. Ltd.
The FDA completed an inspection of Jilin Shulan Synthetic Pharmaceutical Co. Ltd. on November 10, 2017 in Jilin. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 10, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jilin (China)